NPPA computed the Retail Price of Dextromethorphan Hydrobromide IP 10 mg + Bilastine IP 3.3mg + Phenylephrine Hydrochloride IP 5mg

Oct 09, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on October 03, 2024, issued the Computation of Retail Price of Dextromethorphan Hydrobromide IP 10 mg + Bilastine IP 3.3mg + Phenylephrine Hydrochloride IP 5mg.

The following has been stated namely: -

• The Retail Price has been computed based on the data from February, 2024

• The Retail Price has been computed for Each Film Coated Tablet Containing Dextromethorphan Hydrobromide IP 10 mg + Bilastine IP 3.3mg + Phenylephrine Hydrochloride IP 5mg for M/sPure and Cure Healthcare Pvt Ltd (Manufacturer) & M/s Akumentis Healthcare Ltd.

• The Total MAT is 50,56,649

[Notification No. 19(4180)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT